← Open Payments lookup

PAUL BARBERA: Open Payments

NPI 1053459487 · SPARROWS POINT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$546 in 22 payments from 8 companies in 2025. Trend: 2023 $186 · 2024 $212 · 2025 $546

Food & beverage: $546
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$159
Astellas Pharma US Inc6$127
Novo Nordisk Inc4$84
PFIZER INC.2$46
Lilly USA, LLC2$42
Exact Sciences Corporation2$39
GlaxoSmithKline, LLC.2$32
Amgen Inc.1$17

Products named: BREZTRI, Veozah, ELIQUIS, MOUNJARO, Rybelsus, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, Ozempic.

Industry payments across MD — which companies pay providers there.